statistiche ricercatore

Nome	#
Ellagic acid inhibits bladder cancer invasiveness and in vivo tumor growth	405
Antitumor activity of a novel anti-vascular endothelial growth factor receptor-1 monoclonal antibody that does not interfere with ligand binding	343
Activity against melanoma of an anti-vascular endothelial growth factor receptor-1 (VEGFR-1) monoclonal antibody that does not hamper ligand binding	340
Poly(ADP‑ribose) polymerase inhibitor olaparib hampers placental growth factor‑driven activation of myelomonocytic cells.	303
The Anti-Vascular Endothelial Growth Factor Receptor-1 Monoclonal Antibody D16F7 Inhibits Glioma Growth and Angiogenesis In Vivo.	297
Platelet-derived growth factor-C promotes human melanoma aggressiveness through activation of neuropilin-1.	283
Role of VEGFR-1 in melanoma acquired resistance to the BRAF inhibitor vemurafenib	169
The Anti-Vascular Endothelial Growth Factor Receptor 1 (VEGFR-1) D16F7 Monoclonal Antibody Inhibits Melanoma Adhesion to Soluble VEGFR-1 and Tissue Invasion in Response to Placenta Growth Factor	23
A novel and atypical NF-KB pro-inflammatory program regulated by a CamKII-proteasome axis is involved in the early activation of Muller glia by high glucose	17
Targeting of PDGF-C/NRP-1 autocrine loop as a new strategy for counteracting the invasiveness of melanoma resistant to braf inhibitors	13
Impact of Physical Exercise on Melanoma Hallmarks: Current Status of Preclinical and Clinical Research	6
Totale	2.199

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2018/2019	183	0	0	0	0	0	0	0	0	0	48	61	74
2019/2020	613	49	49	43	53	51	61	63	59	65	53	32	35
2020/2021	389	36	39	38	72	30	31	34	46	11	29	19	4
2021/2022	78	4	8	11	3	0	4	4	4	8	8	10	14
2022/2023	153	11	14	6	26	5	36	17	5	12	0	13	8
2023/2024	82	7	3	5	5	12	32	7	1	4	6	0	0
Totale													2.199